A. Spanevello (Tradate, Italy), P. L. Haslam (London, United Kingdom)
Analysis of antioxidant proteins and oxidized proteins in BAL of patients with interstitial lung diseases
P. Rottoli, E. Bargagli, N. Nikiforakis, M. G. Perari, R. Cianti, S. Liberatori, L. Bini, B. Magi (Siena, Italy)
|  |
Adenosine concentration in exhaled breath condensate in the follow-up of lung transplant recipients
E. Barát, E. Huszár, B. Antus, E. Csiszér, I. Horváth (Budapest, Hungary)
| |
Decreased levels of high-density lipoprotein cholesterol in patients with sarcoidosis and relationship with disease activity
A. Tunckale, H. Yanardag, H. Yildiz, T. Yanardag, S. Demirci (Istanbul, Turkey)
| |
Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patient with sarcoidosis
H. Ichikawa, M. Kataoka, M. Ohmori, J. I. Hiramatsu, Y. Tanimoto, A. Kanehiro, M. Tanimoto, Y. Nakata (Okayama, Japan)
| |
Elastic fibers fragmentation of the pulmonary vessels in wegener granulomatosis: a quantitative study
J. M. Barros, E. R. Parras, A. M. Ab'Saber, E. R. Borges, T. Antunes, C. R. R. Carvalho, P. H. N. Saldiva, V. L. Capelozzi, C. S. V. Barbas (Sao Paulo, Brazil)
| |
A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Z. Daniil, G. Kapotsis, P. Kitsanta, M. Karantza, A. Kollintza, C. Roussos, S. Papiris (Athens, Greece)
| |
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner
C. S. Tsobanidou, G. N. Dermitzakis, B. Perin, T. Jivannakis (Thessaloniki, Drama, Greece; Sremska Kamenica, Serbia)
| |
Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects
T. Zak-Nejmark, R. Jankowska, E. Passowicz-Muszynska, M. Marciniak (Wroclaw, Poland)
| |
Apoptosis of circulating and BALF lymphocytes of patients with lung cancer
J. Domagala-Kulawik, G. Hoser, R. Chazan (Warsaw, Poland)
| |
Effect of switching from high dose fluticasone propionate (FP) to FP/salmeterol (FSC) on airway inflammation in asthma
S. J. Wilson, H. M. Rigden, N. Jarjour, M. Laviolette, W. C. Moore, P. M. Dorinsky, S. W. Yancey, R. Djukanovic (Southampton, United Kingdom; Madison, Winston-Salem, Research Triangle Park, United States Of America; Quebec, Canada)
| |
Expression of elastolytic proteases in lung parenchyma from COPD compared to normal subjects and healthy smokers
A. Papi, G. Caramori, K. Ito, P. Casolari, M. Contoli, K. F. Chung, A. Ciaccia, I. M. Adcock, P. J. Barnes (Ferrara, Italy; London, United Kingdom)
| |
A new biological sample: tracheal aspirates from tracheostomized patients
P. Pignatti, G. Moscato, A. Balestrino, M. R. Yacoub, M. Delmastro, G. Brunetti, S. Nava, B. Balbi (Pavia, Gussago, Italy)
| |
Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema
K. Kurashima, N. Takayanagi, T. Kanauchi, D. Tokunaga, Y. Sugita, M. Kanazawa (Konan-machi, Moroyama, Japan)
| |
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
M. Corradi, P. Pignatti, P. Manini, R. Andreoli, M. Goldoni, M. Poppa, G. Moscato, B. Balbi, A. Mutti (Parma, Pavia, Brescia, Italy)
| |
Systemic, upper and lower airway inflammation at exacerbation of COPD
J. R. Hurst, W. R. Perera, T. M. A. Wilkinson, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |
Are symptoms of chronic bronchitis and sputum inflammatory cell counts related to the duration of smoking cessation in COPD?
J. B. Snoeck-Stroband, T. S. Lapperre, M. M. E. Gosman, H. A. Thiadens, J. K. Sont, H. M. Boezen, H. A. M. Kerstjens, D. S. Postma, P. J. Sterk, the GLUCOLD Study Group (Leiden, Groningen, Leiden, Groningen, The Netherlands)
| |
Mitochondrial redox potential and respiration in COPD patients with normal and low BMI
R. A. Rabinovich, E. Ardite, J. Vilaró, R. Bastos, R. Rodriguez-Roisin, J. A. Barbera, J. C. Fernandez-Checa, J. Roca (Barcelona, Spain)
| |
Which markers other than FEV1 reflect disease progression in COPD?
L. G. Franciosi, C. P. Page, B. R. Celli, M. Cazzola, M. J. Walker, M. Danhof, K. F. Rabe, O. E. Della Pasqua (Leiden, The Netherlands; London, Greenford, United Kingdom; Boston, United States Of America; Naples, Italy; Vancouver, Canada)
| |
Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD8+ TLs in lung injury
Z. Daniil, G. Kapotsis, P. Kitsanta, A. Kollintza, C. Roussos, S. Papiris (Athens, Greece)
| |
Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
R. P. Tabuena, S. Nagai, T. Tsutumi, T. Handa, M. Shigematsu, K. Hamada, T. Izumi, M. Mishima (Kyoto, Osaka, Sapporo, Japan)
| |